Drug Type Small molecule drug |
Synonyms |
Target |
Action modulators |
Mechanism ERN1 gene modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic breast cancer | Preclinical | China | 01 Feb 2025 | |
Multiple Myeloma | Preclinical | China | 01 Feb 2025 |